Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells.

Saved in:
Bibliographic Details
Title: Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells.
Authors: Giovannetti E; Dept. Medical Oncology, VUmc Cancer Center Amsterdam, VU University Medical Center, CCA room 1.52, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands. elisa.giovannetti@gmail.com, Labots M, Dekker H, Galvani E, Lind JS, Sciarrillo R, Honeywell R, Smit EF, Verheul HM, Peters GJ
Source: Current pharmaceutical design [Curr Pharm Des] 2013; Vol. 19 (5), pp. 927-39.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9602487 Publication Model: Print Cited Medium: Internet ISSN: 1873-4286 (Electronic) Linking ISSN: 13816128 NLM ISO Abbreviation: Curr Pharm Des Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22973961
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Giovannetti+E%22">Giovannetti E</searchLink>; Dept. Medical Oncology, VUmc Cancer Center Amsterdam, VU University Medical Center, CCA room 1.52, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands. elisa.giovannetti@gmail.com<br /><searchLink fieldCode="AU" term="%22Labots+M%22">Labots M</searchLink><br /><searchLink fieldCode="AU" term="%22Dekker+H%22">Dekker H</searchLink><br /><searchLink fieldCode="AU" term="%22Galvani+E%22">Galvani E</searchLink><br /><searchLink fieldCode="AU" term="%22Lind+JS%22">Lind JS</searchLink><br /><searchLink fieldCode="AU" term="%22Sciarrillo+R%22">Sciarrillo R</searchLink><br /><searchLink fieldCode="AU" term="%22Honeywell+R%22">Honeywell R</searchLink><br /><searchLink fieldCode="AU" term="%22Smit+EF%22">Smit EF</searchLink><br /><searchLink fieldCode="AU" term="%22Verheul+HM%22">Verheul HM</searchLink><br /><searchLink fieldCode="AU" term="%22Peters+GJ%22">Peters GJ</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229602487%22">Current pharmaceutical design</searchLink> [Curr Pharm Des] 2013; Vol. 19 (5), pp. 927-39.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Bentham+Science+Publishers%22">Bentham Science Publishers </searchLink><i>Country of Publication: </i>United Arab Emirates <i>NLM ID: </i>9602487 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4286 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213816128%22">13816128 </searchLink><i>NLM ISO Abbreviation: </i>Curr Pharm Des <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22973961
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 927
    Titles:
      – TitleFull: Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Giovannetti E
      – PersonEntity:
          Name:
            NameFull: Labots M
      – PersonEntity:
          Name:
            NameFull: Dekker H
      – PersonEntity:
          Name:
            NameFull: Galvani E
      – PersonEntity:
          Name:
            NameFull: Lind JS
      – PersonEntity:
          Name:
            NameFull: Sciarrillo R
      – PersonEntity:
          Name:
            NameFull: Honeywell R
      – PersonEntity:
          Name:
            NameFull: Smit EF
      – PersonEntity:
          Name:
            NameFull: Verheul HM
      – PersonEntity:
          Name:
            NameFull: Peters GJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2013
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1873-4286
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Current pharmaceutical design
              Type: main
ResultId 1